[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100285925":3},{"organization":4,"outcomesModule":7,"designInfo":16,"detailedDescription":19,"studyPopulation":20,"armGroups":21,"interventions":27,"overallOfficials":11,"centralContacts":32,"locations":42,"responsibleParty":60,"collaborators":11,"id":64,"slug":65,"hasResults":66,"nctId":67,"briefTitle":68,"officialTitle":68,"acronym":11,"eligibilityCriteria":69,"healthyVolunteers":66,"sex":70,"minAge":71,"maxAge":11,"enrollmentInfo":72,"targetDuration":11,"studyType":75,"phases":11,"briefSummary":76,"conditions":77,"keywords":79,"overallStatus":45,"whyStopped":11,"lastUpdateSubmitDate":83,"lastUpdatePostDateStruct":84,"startDateStruct":87,"completionDateStruct":89,"leadSponsor":91,"locationsCount":92},{"fullName":5,"class":6},"Sun Yat-sen University","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":11,"otherOutcomes":11},[9,13],{"measure":10,"description":11,"timeFrame":12},"All-cause mortality and cardiovascular mortality of LN patients",null,"10years",{"measure":14,"description":15,"timeFrame":12},"A composite renal outcome of LN patients","The composite renal outcome defined as doubling of serum creatinine and ESRD (defined as initiation of dialysis or kidney transplantation).",{"allocation":11,"interventionModel":11,"interventionModelDescription":11,"primaryPurpose":11,"observationalModel":17,"timePerspective":18,"maskingInfo":11},"COHORT","PROSPECTIVE","The investigators are registering Lupus nephritis (LN) and developing a LN database in China. Patients' demographic characteristics (including age, gender, height, weight, BMI, smoking, drinking, and education etc.), clinical characteristics (including systolic blood pressure, diastolic blood pressure, and lab measurements of whole blood, serum, urine etc.), complications, drug information at the baseline will be collected. Patients will be follow-up every year, the demographic and clinical characteristics, complications; drug information of patients will be collected at each visit. We will also record the outcome at each visit, such as mortality (including all-cause mortality and cardiovascular disease mortality), end-stage renal disease (ESRD) or serum creatinine doubling. The patient survival and renal survival will be compared using the LN database.","Lupus nephritis patients",[22],{"label":23,"type":11,"description":24,"interventionNames":25},"LN patients","Patients diagnosis as lupus nephritis",[26],"Other: No Intervention",[28],{"type":6,"name":29,"description":30,"armGroupLabels":31,"otherNames":11},"No Intervention","Registration of all LN patients in the First Affiliated Hospital of Sun Yat-sen University and other hospitals which have signed the contract in China.",[23],[33,37],{"name":34,"role":35,"phone":11,"phoneExt":11,"email":36},"Xueqing Yu, M.D. & Ph.D","CONTACT","yuxq@mail.sysu.edu.cn",{"name":38,"role":35,"phone":39,"phoneExt":40,"email":41},"Wei Chen, M.D. & Ph.D","8620-87755766","8843","vvchen66@qq.com",[43],{"facility":44,"status":45,"city":46,"state":47,"zip":48,"country":49,"countryCode":50,"cosmosGeoPoint":51,"geoPoint":56,"contacts":57},"The First Affiliated Hospital, Sun Yat-sen University","RECRUITING","Guangzhou","Guangdong","510080","China","CN",{"type":52,"coordinates":53},"Point",[54,55],113.25,23.11667,{"lat":55,"lon":54},[58],{"name":59,"role":35,"phone":11,"phoneExt":11,"email":36},"Xueqing Yu, M.D. & Ph.D.",{"type":61,"investigatorFullName":62,"investigatorTitle":63,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"PRINCIPAL_INVESTIGATOR","Xue Qing Yu","Professor","100285925","high-quality-evidence-of-chinese-lupus-nephritis-help-100285925",false,"NCT03001973","High Quality Evidence of Chinese Lupus Nephritis (HELP)","Inclusion Criteria:\n\n* Patients who diagnosis as lupus nephritis\n\nExclusion Criteria:\n\n* No","ALL","14 Years",{"count":73,"type":74},5000,"ESTIMATED","OBSERVATIONAL","The investigators are registering LN patients at recruited hospitals and developing a LN database in China. Patients will be follow-up every year, and both baseline and follow-up information will be entered into the registration system.",[78],"Lupus Nephritis",[80,81,82],"Lupus nephritis","Patient survival","Renal survival","2026-09-10",{"date":85,"type":86},"2026-09-15","ACTUAL",{"date":88,"type":86},"2013-11",{"date":90,"type":74},"2029-12",{"name":5,"class":6},1]